Stockreport

Tango Therapeutics Second Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF Net loss: US$25.6m (loss widened by 23% from 2Q 2023). US$0.24 loss per share (further deteriorated from US$0.23 loss in 2Q 2023). All figures shown in the chart ab [Read more]